Impact of serotonin transporter and catechol-O-methyl transferase genes polymorphism on gastrointestinal dysfunction in Swedish and Japanese familial amyloidotic polyneuropathy patients
- 31 December 2008
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 398 (1-2) , 10-14
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Meta‐analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndromeAlimentary Pharmacology & Therapeutics, 2007
- Serotonin transporter gene polymorphism and irritable bowel syndromeNeurogastroenterology & Motility, 2006
- Serotonin Transporter Promoter Gain-of-Function Genotypes Are Linked to Obsessive-Compulsive DisorderThe American Journal of Human Genetics, 2006
- The Relationship between COMT Genotype and the Clinical Effectiveness of Tolcapone, a COMT Inhibitor, in Patients with Parkinson's DiseaseClinical Neuropharmacology, 2000
- A pilot evaluation of the tolerability, safety, and efficacy of tolcapone alone and in combination with oral selegiline in untreated Parkinson's disease patientsMovement Disorders, 1998
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type)Biochemical and Biophysical Research Communications, 1983
- Polymorphism of human plasma thyroxine binding prealbuminBiochemical and Biophysical Research Communications, 1983
- Familial Amyloidosis with PolyneuropathyActa Medica Scandinavica, 1983
- Familial amyloidosis with gastrointestinal neuropathy.Gut, 1968